Once-Monthly Subcutaneous C.E.R.A. Maintains Stable Hemoglobin Control in Patients with Chronic Kidney Disease on Dialysis and Converted Directly from Epoetin One to Three Times Weekly-Reference-Cited by-同舟云学术

Once-Monthly Subcutaneous C.E.R.A. Maintains Stable Hemoglobin Control in Patients with Chronic Kidney Disease on Dialysis and Converted Directly from Epoetin One to Three Times Weekly

Published:2007-05-23 Issue:4 Volume:2 Page:637-646
ISSN:1555-9041
Container-title:Clinical Journal of the American Society of Nephrology
language:en
Short-container-title:CJASN

Author:

Sulowicz Wladyslaw,Locatelli Francesco,Ryckelynck Jean-Philippe,Balla Jozsef,Csiky Botond,Harris Kevin,Ehrhard Patricia,Beyer Ulrich

Publisher

American Society of Nephrology (ASN)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Reference43 articles.

1. Association of Kidney Function With Anemia

2. Epidemiology of anemia associated with chronic renal insufficiency

3. The prevalence of anemia in patients with chronic kidney disease

4. The Quality of Life of Hemodialysis Recipients Treated With Recombinant Human Erythropoietin

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic Growth Factors;Pharmaceutical Biotechnology;2024

2. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-02-13

3. Anemia in Chronic Renal Disease;Pediatric Kidney Disease;2023

4. Subcutaneous C.E.R.A. for the Maintenance Treatment of Anemia in Pediatric Patients With CKD: A Phase 2, Open-Label, Single-Arm, Multicenter Study;American Journal of Kidney Diseases;2022-12

5. Monthly Continuous Erythropoietin Receptor Activator Versus Weekly Epoetin-Beta, Similar Hemoglobinization but Different Anisocytosis Degree in Hemodialysis Patients: A Randomized Controlled Trial;Journal of Hematology;2021-12